1. Home
  2. TSHA vs LOMA Comparison

TSHA vs LOMA Comparison

Compare TSHA & LOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSHA
  • LOMA
  • Stock Information
  • Founded
  • TSHA 2019
  • LOMA 1926
  • Country
  • TSHA United States
  • LOMA Argentina
  • Employees
  • TSHA N/A
  • LOMA N/A
  • Industry
  • TSHA Biotechnology: Pharmaceutical Preparations
  • LOMA Building Materials
  • Sector
  • TSHA Health Care
  • LOMA Industrials
  • Exchange
  • TSHA Nasdaq
  • LOMA Nasdaq
  • Market Cap
  • TSHA 1.4B
  • LOMA 1.3B
  • IPO Year
  • TSHA 2020
  • LOMA 2017
  • Fundamental
  • Price
  • TSHA $4.72
  • LOMA $7.80
  • Analyst Decision
  • TSHA Strong Buy
  • LOMA Strong Buy
  • Analyst Count
  • TSHA 8
  • LOMA 2
  • Target Price
  • TSHA $9.63
  • LOMA $15.00
  • AVG Volume (30 Days)
  • TSHA 11.3M
  • LOMA 716.2K
  • Earning Date
  • TSHA 11-12-2025
  • LOMA 11-05-2025
  • Dividend Yield
  • TSHA N/A
  • LOMA N/A
  • EPS Growth
  • TSHA N/A
  • LOMA N/A
  • EPS
  • TSHA N/A
  • LOMA 0.37
  • Revenue
  • TSHA $8,098,000.00
  • LOMA $559,741,122.00
  • Revenue This Year
  • TSHA N/A
  • LOMA $22.92
  • Revenue Next Year
  • TSHA N/A
  • LOMA $25.84
  • P/E Ratio
  • TSHA N/A
  • LOMA $21.09
  • Revenue Growth
  • TSHA N/A
  • LOMA N/A
  • 52 Week Low
  • TSHA $1.05
  • LOMA $7.04
  • 52 Week High
  • TSHA $5.51
  • LOMA $14.17
  • Technical
  • Relative Strength Index (RSI)
  • TSHA 59.56
  • LOMA 45.24
  • Support Level
  • TSHA $4.80
  • LOMA $7.69
  • Resistance Level
  • TSHA $5.51
  • LOMA $8.54
  • Average True Range (ATR)
  • TSHA 0.44
  • LOMA 0.45
  • MACD
  • TSHA 0.04
  • LOMA 0.13
  • Stochastic Oscillator
  • TSHA 66.02
  • LOMA 50.33

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

About LOMA Loma Negra Compania Industrial Argentina Sociedad Anonima ADS

Loma Negra Cia Industria Argentina SA is a cement producer in Argentina. The company operates in five segments: Cement, masonry cement, and lime; Concrete; Rail services; Aggregates; and Others. The majority of its revenue derives from Cement, masonry cement, and lime segments.

Share on Social Networks: